Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: A retrospective study using the DAPI database

Journal of Hypertension

Volumn 29, Issue 9, 2011, Pages 1837-1845

  Ude, Miriam ^a   Schuessel, Katrin ^b   Quinzler, Renate ^b   Leuner, Kristina ^a   Müller, Walter E ^a   Schulz, Martin ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b German Institute for Drug Use Evaluation   (Germany)

Author keywords

generic substitution; generic switch; medication possession ratio; patent expiry; pharmacy refill compliance; prescription database; ramipril

Indexed keywords

DIURETIC AGENT; FELODIPINE; GENERIC DRUG; RAMIPRIL;

ARTICLE; DRUG SUBSTITUTION; EXPIRATION DATE; FOLLOW UP; HEALTH INSURANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MONOTHERAPY; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 80051950674     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834942be     Document Type: Article

References (24)

1. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO Press; 2003.
2. van Wijk B, Klungel O, Heerdink ER, de Boer A. Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. J Clin Epidemiol 2006; 59:11-17. (Pubitemid 41797470)
3. Munger M, van Tassell B, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed 2007; 9:58.
4. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: WHO Press; 2009.
5. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333:15-20.
6. Perreault S, Dragomir A, Roy L, White M, Blais L, Lalonde L, et al. Adherence level of antihypertensive agents in coronary artery disease. Br J Clin Pharmacol 2010; 69:74-84.
7. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120:1598-1605.
8. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-497. (Pubitemid 41127293)
9. Cramer J, Roy A, Burrell A, Fairchild C, Fuldeore M, Ollendorf D, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008; 11:44-47. (Pubitemid 351160875)
10. Dü sing R. Adverse events, compliance, and changes in therapy. Curr Hypertens Rep 2001; 3:488-492.
11. Ha°konsen H, Eilertsen M, Borge H, Toverud E. Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin 2009; 25:2515-2521.
12. Van Wijk BL, Heerdink ER, de Boer A. Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother 2006; 40:15-20. (Pubitemid 43221468)
13. FachInfo Service. N.N. SPC Delix 2.5mg tablets/Delix 5mg tablets. 2009. http://www.fachinfo.de. [Accessed 6 July 2010]
14. N.N. Clear and brief [in German]. Arzneitelegramm 2004; 35:15.
15. Bundesministerium fü r Gesundheit und Soziale Sicherung. Statutory health insurance funds. Members, family members, membership rate and sickness absence [in German]. 2004. http://www.bmg.bund.de/. [Accessed 14 December 2010]
16. ABDATA Pharma Daten Service. ABDA database and ABDA stocklist [in German]. Bi-monthly update. Eschborn: ABDATA Pharma Daten Service; 2002-2006.
17. Arbeitsgruppe Erhebung und Nutzung von Sekundä rdaten der Deutschen Gesellschaft für Sozialmedizin und Prä vention, Arbeitsgruppe Epidemiologische Methoden der Deutschen Gesellschaft für Epidemiologie, Arbeitsgruppe der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie, Arbeitsgruppe der Gesellschaft für Sozialmedizin und Prä vention. GPS: good practice secondary data analysis-revisied version [in German]. Gesundheitswesen 2008; 70:54-60.
18. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2010. 2010. http://www.whocc.no/atc-ddd-index/. [Accessed 6 July 2010]
19. Lachaine J, Petrella R, Merikle E, Ali F. Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data. Can J Cardiol 2008; 24:269-273. (Pubitemid 351771460)
20. Friedman O, McAlister F, Yun L, Campbell N, Tu K. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario. Am J Med 2010; 123:173-181.
21. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007; 120:26-32. (Pubitemid 46026987)
22. Halpern M, Khan Z, Schmier J, Burnier M, Caro J, Cramer J, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006; 47:1039-1048. (Pubitemid 44289157)
23. Simons L, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia-wide experience. Med J Aust 2008; 188: 224-227.
24. Yoon J, Ettner S. Cost-sharing and adherence to antihypertensives for low and high adherers. Am J Manag Care 2009; 15:833-840.